Congress of European Crohn's and Colitis Organisation

Meeting News

Hyperbaric oxygen therapy benefits hospitalized UC patients

February 23, 2017
Hyperbaric oxygen therapy was effective, safe and well tolerated in hospitalized patients with ulcerative colitis experiencing moderate-to-severe…
Meeting News

FMT for UC induces remission at low dose, short duration

February 22, 2017
Fecal microbiota therapy that was prepared anaerobically from pooled donor material was more effective than placebo at 1 week for inducing remission…
Meeting News

GEMINI: Entyvio in IBD safe, effective through 5 years

February 21, 2017
Long-term use of Entyvio was shown to be safe and effective in patients with moderate-to-severe ulcerative colitis and Crohn’s disease through…
Meeting News

Biosimilar shows comparable safety, efficacy to Remicade in Crohn's

February 20, 2017
Treatment with the infliximab biosimilar, Inflectra, demonstrated comparable safety and efficacy to the originator, Remicade, in a phase 3 randomized…
Meeting News

Cx601 stem cell therapy maintains remission of complex perianal fistulas through 1 year in Crohn's

February 20, 2017
Patients with Crohn’s disease achieved sustained remission of treatment-refractory complex perianal fistulas through 52 weeks after treatment…
Meeting News

Stelara maintains clinical response, remission through 2 years in Crohn's disease

February 17, 2017
Patients with moderate-to-severe active Crohn’s disease maintained clinical response and remission with Stelara for up to 2 years, according to…
Meeting News Coverage

FITZROY: Filgotinib induces clinical remission in moderate-to-severe Crohn’s disease

April 5, 2016
Filgotinib safely and effectively induced clinical remission and response in patients with moderate-to-severe Crohn’s disease, according to…
Meeting News Coverage

FMT induces remission in resistant ulcerative colitis

April 4, 2016
Intense multi-donor fecal microbiota transplantation administered via colonoscopy and enema effectively induced clinical and endoscopic remission in…
Meeting News Coverage

TOUCHSTONE: Patients with UC achieve histological improvements with ozanimod

March 24, 2016
Patients with moderate to severe ulcerative colitis achieved histologic improvement and histologic remission with 1 mg ozanimod, according to results…
Meeting News Coverage

Superior endoscopic improvement achieved when azathioprine added to Humira therapy in Crohn’s disease

March 23, 2016
Comparable clinical efficacy was achieved with Humira monotherapy and combination therapy with Humira and azathioprine in patients with Crohn’s…

Meeting Calendar

European Crohn's and Colitis Organisation Congress

February 15, 2017 - February 18, 2017

Advertisement
Advertisement